Return-path: Envelope-to: lojban@lojban.org Delivery-date: Thu, 09 Sep 2021 13:19:26 -0700 Received: from mail.garakas.casa ([45.144.213.60]:36275) by stodi.digitalkingdom.org with esmtp (Exim 4.94) (envelope-from ) id 1mOQW3-00BXp7-Gy for lojban@lojban.org; Thu, 09 Sep 2021 13:19:25 -0700 DKIM-Signature: v=1; a=rsa-sha1; c=relaxed/relaxed; s=dkim; d=garakas.casa; h=Date:From:To:Subject:MIME-Version:Content-Type:List-Unsubscribe:Message-ID; i=provisine@garakas.casa; bh=8jd55R4mWR9mH3/MC5A91WxLnLE=; b=ncu1zzkFcWbU8sAJwgRJKhcwYJuEPX7tjTml1qPLh7fS1mJCc+cnRU2Wo2RwkosukGx+JPO+0xXi l5I/YOtPe7HGCPt/5dZYSGjxaWQ4PSo6uTN8FX1XRaQn3CNTS44FocIgDzLIEvwSvOTNQngdIJDG 6TS3vgv4qGJvOYobN9o= DomainKey-Signature: a=rsa-sha1; c=nofws; q=dns; s=dkim; d=garakas.casa; b=dyoHn9rYr3VYBXGbdcI8BxtSMZxY65BOpUlZI4JwInktLrQOaQWfIlcAf0clXMhpHtROx8sKKrXd rp5HjEdZmC78JhyyQcZs7s2nB7+DMmO+dvGEpUv/HM609+XcErfGamZiQFfw8CT5n3ETssAmuc+x xTjey5g4xGtz1RZ/tp4=; Received: by mail.garakas.casa id h79m4m0001ga for ; Thu, 9 Sep 2021 15:35:02 -0400 (envelope-from ) Date: Thu, 9 Sep 2021 15:35:02 -0400 From: Provisine To: Subject: Pharma Cohorts Hid This 20/20 Vision Formula From You MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_Part_388_231965295.1631216097468" List-Unsubscribe: Message-ID: <0.0.0.2B.1D7A5B1C8C0CDB4.4D3C1E@mail.garakas.casa> X-Spam-Score: 4.6 (++++) X-Spam_score: 4.6 X-Spam_score_int: 46 X-Spam_bar: ++++ X-Spam-Report: Spam detection software, running on the system "stodi.digitalkingdom.org", has NOT identified this incoming email as spam. The original message has been attached to this so you can view it or label similar future email. If you have any questions, see the administrator of that system for details. Content preview: If you are unable to see images,Click Here http://www.garakas.casa/largeness-bimolecular/7ec4F2395Eh86N12i1660dS2e43Y18thscFDrfhscFDrEsvZ11rRPnoSRSoJe5tTS107bjJH@to Pharma Exec Caught Hiding 20/20 Vision Formula Content analysis details: (4.6 points, 5.0 required) pts rule name description ---- ---------------------- -------------------------------------------------- 0.8 BAYES_50 BODY: Bayes spam probability is 40 to 60% [score: 0.5620] 1.2 URIBL_ABUSE_SURBL Contains an URL listed in the ABUSE SURBL blocklist [URIs: garakas.casa] 0.0 URIBL_BLOCKED ADMINISTRATOR NOTICE: The query to URIBL was blocked. See http://wiki.apache.org/spamassassin/DnsBlocklists#dnsbl-block for more information. [URIs: garakas.casa] 2.7 RCVD_IN_PSBL RBL: Received via a relay in PSBL [45.144.213.60 listed in psbl.surriel.com] -0.0 RCVD_IN_MSPIKE_H2 RBL: Average reputation (+2) [45.144.213.60 listed in wl.mailspike.net] -0.0 SPF_PASS SPF: sender matches SPF record 0.0 SPF_HELO_NONE SPF: HELO does not publish an SPF Record 0.0 HTML_MESSAGE BODY: HTML included in message -0.1 DKIM_VALID_AU Message has a valid DKIM or DK signature from author's domain -0.1 DKIM_VALID_EF Message has a valid DKIM or DK signature from envelope-from domain 0.1 DKIM_SIGNED Message has a DKIM or DK signature, not necessarily valid -0.1 DKIM_VALID Message has at least one valid DKIM or DK signature ------=_Part_388_231965295.1631216097468 Content-Type: text/plain; charset=utf-8 Content-Transfer-Encoding: 7bit If you are unable to see images,Click Here http://www.garakas.casa/largeness-bimolecular/7ec4F2395Eh86N12i1660dS2e43Y18thscFDrfhscFDrEsvZ11rRPnoSRSoJe5tTS107bjJH@to Pharma Exec Caught Hiding 20/20 Vision Formula Big Pharma has done it again! And this time it's not looking pretty for them, as recent investigation has shown they've been hiding the 20/20 vision secret inside one of their remote labs. Lead investigators say although it's within a company's legal right to release products at their own will, this time was done improperly and it might cost someone's freedom. The same source told reporters that certain pharma execs have altered the real results of several clinical studies made on vision loss. Although the research initially showed a 98% improvement of eyesight with over 4,500 patients getting staggering results, they buried it because the solution was too cheap for them to sell. Big Pharma was forced to publicly expose the real results of the findings. Plus THE REAL formula that gets 20/20 vision. As the research shows, it can get people crystal clear eyesight, no matter if the degree of their vision loss or if they are farsighted, nearsighted or suffer from macular degeneration, RP, cataracts or diabetic retinopathy. Get their findings and formula while this is still online. . . If you do not wish to receive future messages click here to unsubscribe 200 Continental Drive, Suite 401, Newark, DE, 19713, US http://www.garakas.casa/abrogates-lookout/17a4p2395n8Nr617c1X660QXeNJO2e43W18chscFDrfhscFDrEsvZ11MRPnoSRSoJe5rxJ107zM@LHto ------=_Part_388_231965295.1631216097468 Content-Type: text/html; charset=us-ascii Content-Transfer-Encoding: 7bit Provisine  
If you are unable to see images, Click Here


 

 
Big Pharma has done it again!

And this time it's not looking pretty for them, as recent investigation has shown they've been hiding  the 20/20 vision secret inside one of their remote labs.

Lead investigators say although it's within a company's legal right to release products at their own will, this time was done improperly and it might cost someone's freedom.

The same source told reporters that certain pharma execs have altered the real results of several clinical studies made on vision loss.






Although the research initially showed a 98% improvement of eyesight with over 4,500 patients getting staggering results, they buried it because the solution was too cheap for them to sell.

Big Pharma was forced to publicly expose the real results of the findings.

Plus THE REAL formula that gets 20/20 vision.

As the research shows, it can get people crystal clear eyesight, no matter if the degree of their vision loss or if they are farsighted, nearsighted or suffer from macular degeneration, RP, cataracts or diabetic retinopathy.

Get their findings and formula while this is still online...





 
If you do not wish to receive future messages
click here to  unsubscribe
200 Continental Drive, Suite 401, Newark, DE, 19713, US

------=_Part_388_231965295.1631216097468--